Equities

OraSure Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

OraSure Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.75
  • Today's Change-0.05 / -1.79%
  • Shares traded358.50k
  • 1 Year change-29.31%
  • Beta0.9025
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.

  • Revenue in USD (TTM)125.70m
  • Net income in USD-60.24m
  • Incorporated2000
  • Employees501.00
  • Location
    OraSure Technologies Inc220 E First StBETHLEHEM 18015United StatesUSA
  • Phone+1 (503) 641-6115
  • Fax+1 (610) 882-1830
  • Websitehttps://www.orasure.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
OSUR:NSQ since
announced
Transaction
value
Biomedomics IncAnnounced05 Nov 202505 Nov 2025Announced7.00%4.00m
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nano-X Imaging Ltd12.30m-55.71m157.80m165.00--0.9513--12.83-0.8839-0.88390.1952.400.068313.177.1874,557.58-30.95-28.17-33.30-31.20-98.04---452.82-1,072.253.93--0.0201--13.91--11.95--85.79--
Acme United Corp194.96m10.02m168.37m633.0018.171.4510.360.86362.432.4347.3530.411.152.036.35307,993.705.927.266.818.5439.5136.345.145.681.758.570.196218.401.566.42-43.6712.7033.594.56
Citrine Global Corp0.00-1.74m169.70m18.00---------0.0016-0.00160.00-0.00310.00----0.00-118.80-238.43-----------186,483.40---2.10--------25.99------
Accendra Health Inc6.71bn-410.53m173.26m13.50k------0.0258-5.33-17.4186.97-5.561.477.5915.52496,837.20-9.01-0.3346-17.40-0.524826.1318.20-6.12-0.1460.83861.671.25--3.553.04-778.15--34.30--
Rapid Micro Biosystems Inc30.52m-44.29m173.30m163.00--3.91--5.68-0.9984-0.99840.68841.000.32091.336.40187,257.70-46.56-38.13-56.14-43.367.72-27.98-145.11-253.022.95--0.3003--24.5711.1810.63---4.24--
Lucid Diagnostics Inc4.40m-65.84m174.13m72.00------39.58-0.8968-0.89680.05260.19730.116112.2414.9461,097.22-140.60-139.37-301.55-297.39-58.13---1,211.30-2,492.791.88--0.4633--79.00---0.6817------
Edap Tms SA (ADR)75.71m-23.29m174.59m310.00--6.31--2.31-0.6221-0.62212.020.74010.90812.083.62244,219.90-27.94-11.18-49.24-15.8643.2442.19-30.77-16.630.9729--0.2062--6.117.3810.20--55.92--
Stereotaxis Inc30.07m-24.91m185.72m139.00--28.93--6.18-0.281-0.2810.33930.12660.62321.474.54216,359.70-48.96-31.30-85.25-43.3153.0762.81-78.56-56.040.8108--0.00--0.5491-1.41-14.95--2.89--
OraSure Technologies Inc125.70m-60.24m197.27m501.00--0.549--1.57-0.8107-0.81071.695.010.28342.074.91250,904.20-13.08-0.8506-14.16-0.959640.4144.80-46.15-1.396.20--0.0005---54.173.75-136.34---16.43--
Electromed Inc66.22m8.20m200.76m177.0026.104.5321.333.030.92950.92957.505.351.294.042.70374,118.7015.999.3318.9911.0478.0476.5612.388.404.66--0.000.0016.9714.5346.3512.62-20.72--
Utah Medical Products Inc38.63m11.62m204.24m155.0018.131.7414.045.293.543.5411.7536.910.3071.9210.38249,245.209.2412.089.4812.5357.1060.8830.0831.0429.36--0.0037.43-18.56-2.70-16.60-0.8254-59.491.83
SANUWAVE Health Inc41.28m-7.04m213.46m46.00------5.17-0.9346-0.93464.68-0.34181.441.7511.07897,456.50-24.53-124.81----78.2671.67-17.06-144.710.8080.09991.14--59.9999.65-21.56--55.47--
Orchestra Biomed Holdings Inc2.82m-75.10m216.26m70.00--4.94--76.74-1.82-1.820.06760.77460.03130.657833.7540,257.14-83.39---104.85--93.01---2,665.05--4.72--0.2451---4.42---24.23------
KORU Medical Systems Inc39.07m-3.71m216.33m80.00--13.13--5.54-0.0807-0.08070.84820.35571.433.537.39488,383.00-13.62-19.85-18.41-23.1662.3259.62-9.50-24.861.92--0.0335--17.987.7555.85--25.82--
CapsoVision Inc13.09m-22.56m226.25m----11.06--17.29-0.4873-0.48730.28260.4368----------------53.13---172.37--4.50--0.00--20.54---76.01------
908 Devices Inc57.64m-57.10m234.89m246.00--1.72--4.08-1.61-0.11161.623.770.31231.764.17234,296.80-30.94-18.01-37.82-19.6749.3552.89-99.07-78.453.12--0.00--18.7227.11-98.37--8.96--
Data as of Feb 13 2026. Currency figures normalised to OraSure Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

47.42%Per cent of shares held by top holders
HolderShares% Held
Private Management Group, Inc.as of 31 Dec 20255.40m7.52%
BlackRock Fund Advisorsas of 31 Dec 20255.35m7.46%
Neuberger Berman Investment Advisers LLCas of 31 Dec 20253.98m5.56%
Altai Capital Management LPas of 15 Jan 20263.74m5.22%
The Vanguard Group, Inc.as of 31 Dec 20253.62m5.05%
Dimensional Fund Advisors LPas of 31 Dec 20253.09m4.31%
Systematic Financial Management LPas of 31 Dec 20252.48m3.45%
Renaissance Technologies LLCas of 31 Dec 20252.15m2.99%
Millennium Management LLCas of 30 Sep 20252.11m2.95%
Cannell Capital LLCas of 30 Sep 20252.10m2.93%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.